<DOC>
	<DOC>NCT00771927</DOC>
	<brief_summary>SP942 is a non-interventional post-authorization safety study (PASS) to evaluate the long-term safety and tolerability of Vimpat® (Lacosamide, LCM) as add-on treatment in patients with Epilepsy 16 years and older with partial-onset seizures who are uncontrolled on current therapy. Using reported adverse events, the incidence of certain cardiovascular and psychiatric events will be evaluated.</brief_summary>
	<brief_title>Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>This study includes any subject 16 years or older who has an Epilepsy diagnosis with PartialOnset Seizures; and whose Seizure activity is uncontrolled on current therapy Patients who are prescribed Vimpat or any other addon Antiepileptic Drug (AED) may be included in the study The initiation of an addon AED therapy can not be more than 2 days before the patient's start of the study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Vimpat®</keyword>
	<keyword>Lacosamide</keyword>
	<keyword>LCM</keyword>
	<keyword>epilepsy</keyword>
	<keyword>epilepsies</keyword>
	<keyword>seizure</keyword>
	<keyword>partial seizure</keyword>
	<keyword>partial onset</keyword>
	<keyword>seizure disorder</keyword>
	<keyword>single seizure</keyword>
	<keyword>motor seizure</keyword>
	<keyword>convulsions</keyword>
	<keyword>add-on</keyword>
	<keyword>AED</keyword>
	<keyword>anti-epileptic</keyword>
	<keyword>anti-epileptic drug</keyword>
	<keyword>seizure control</keyword>
	<keyword>open-label</keyword>
	<keyword>post authorization</keyword>
	<keyword>PASS</keyword>
	<keyword>late stage</keyword>
	<keyword>trial</keyword>
	<keyword>study</keyword>
	<keyword>phase 4</keyword>
	<keyword>phase IV</keyword>
</DOC>